Stryker Corporation (SYK): Today's Featured Health Services Laggard
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
.
(
) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 1.3%. By the end of trading, Stryker Corporation fell 55 cents (-1%) to $54.05 on average volume. Throughout the day, 2.5 million shares of Stryker Corporation exchanged hands as compared to its average daily volume of 2.1 million shares. The stock ranged in price between $53.86-$55.08 after having opened the day at $54.82 as compared to the previous trading day's close of $54.60. Other companies within the Health Services industry that declined today were:
(
), down 5.2%,
(
), down 4.5%,
(
), down 3.4%, and
(
), down 3.3%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Stryker Corporation has a market cap of $20.61 billion and is part of the health care sector. The company has a P/E ratio of 14.6, below the S&P 500 P/E ratio of 17.7. Shares are up 9.1% year to date as of the close of trading on Wednesday. Currently there are 13 analysts that rate Stryker Corporation a buy, no analysts rate it a sell, and 13 rate it a hold.
TheStreet Ratings rates Stryker Corporation as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, growth in earnings per share and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.
- You can view the full Stryker Ratings Report.
On the positive front,
(
), up 12.2%,
(
), up 11.8%,
(
), up 11.5%, and
NeuroMetrix
(
NUROD
), up 8.3%, were all gainers within the health services industry with
(
) being today's featured health services industry leader.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider
Health Care Select Sector SPDR
(
) while those bearish on the health services industry could consider
ProShares Ultra Short Health Care
(
).
- Find other investment ideas from our top rated ETFs lists.
Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade
.
null